Two Sigma Securities, LLC Sesen Bio, Inc. Transaction History

Two Sigma Securities, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.49 - $0.61 $41,017 - $51,062	83,709 New	83,709 $51,000
Q2 2022 Aug 15, 2022	BUY	$0.38 - $0.89 $8,546 - $20,017	22,492 Added 130.17%	39,771 $32,000
Q1 2022 May 16, 2022	SELL	$0.58 - $0.86 $33,023 - $48,965	-56,937 Reduced 76.72%	17,279 $10,000
Q4 2021 Feb 14, 2022	SELL	$0.73 - $1.28 $41,193 - $72,229	-56,429 Reduced 43.19%	74,216 $60,000
Q3 2021 Nov 15, 2021	BUY	$0.77 - $4.91 $100,596 - $641,466	130,645 New	130,645 $104,000
Q4 2020 Feb 16, 2021	SELL	$1.01 - $1.77 $20,629 - $36,152	-20,425 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.67 - $1.4 $13,684 - $28,595	20,425 New	20,425 $29,000
Q3 2019 Nov 14, 2019	SELL	$1.04 - $1.51 $41,219 - $59,847	-39,634 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.95 - $2.46 $37,652 - $97,499	39,634 New	39,634 $59,000
Q3 2018 Nov 14, 2018	SELL	$1.54 - $2.38 $17,637 - $27,258	-11,453 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.04 - $3.29 $11,911 - $37,680	11,453 New	11,453 $22,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.